Drug Trial Radar · NCT01242514
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)
Last checked: Nov 20, 2026Latest source record: Apr 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,917
Actual
Start
Jan 2011
Primary completion
Jan 2015
Study completion Jan 2015
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Nov 17, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients with rheumatoid arthritis (RA).
Conditions
- Rheumatoid Arthritis
Interventions
FostamatinibDrug
Fostamatinib 100mg twice daily
FostamatinibDrug
Fostamatinib 150mg once daily
FostamatinibDrug
Fostamatinib 100mg once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients Who Had at Least 1 Adverse Event in Any CategoryTime frame: Entry in extension to end of study (variable duration; maximum 109 weeks)
Locations
308 sites in 31 countries. Site status is shown where the registry gives one.
Research Site
Anniston, Alabama
Research Site
Birmingham, Alabama
Research Site
Huntsville, Alabama
Research Site
Tuscaloosa, Alabama
Research Site
Glendale, Arizona
Research Site
Mesa, Arizona
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Tucson, Arizona
Research Site
Hot Springs, Arkansas
Research Site
Anaheim, California
Research Site
Fountain Valley, California
Research Site
Huntington Beach, California
Research Site
La Jolla, California
Research Site
Long Beach, California
Research Site
Palo Alto, California
Research Site
Roseville, California
Research Site
Santa Maria, California
Research Site
Santa Monica, California
Research Site
Torrance, California
Research Site
Upland, California
Research Site
Colorado Springs, Colorado
Research Site
Bridgeport, Connecticut
Research Site
Danbury, Connecticut
Research Site
Trumbull, Connecticut
Research Site
Lewes, Delaware
Research Site
Boca Raton, Florida
Research Site
Brandon, Florida
Research Site
Daytona Beach, Florida
Research Site
Fort Lauderdale, Florida
Research Site
Jacksonville, Florida
Research Site
Miami, Florida
Research Site
Ocala, Florida
Research Site
Orlando, Florida
Research Site
Palm Harbor, Florida
Research Site
Pinellas Park, Florida
Research Site
Tampa, Florida
Research Site
Tavares, Florida
Research Site
Venice, Florida
Research Site
Zephyrhills, Florida
Showing 40 of 308 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.